ClinicalTrialsFinder

EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD) Clinical Trials in Birmingham, England

1 recruitingBirmingham, England, United Kingdom

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914